CareX

Illkirch-Graffenstaden, Grand Est, France

http://www.carex.fr/

Company profile

CareX company profile

CareX SA is a biopharmaceutical company that develops novel treatments for metabolic and immune system disorders which includes diabetes and obesity. The company focuses on metabolic syndrome, a cluster of inter-related disorders of the body’s metabolism, including high blood pressure, high insulin levels, excess body weight, and abnormal cholesterol levels, that exposes individuals to the development of type 2 diabetes, heart diseases, and strokes. CareX SA is a France-based company that was founded in 2001 and the company was acquired by 7TM Pharma on May 24, 2006.

Business identity

Website: http://www.carex.fr/
Contact email: [email protected]
Operating status: Closed
Company type: For Profit
Founded: 2001-01-01

Headquarters

Headquarters: Illkirch-Graffenstaden, Grand Est, France
Postal code: 67412
Country code: FR
Continent: Europe

Capital profile

Funding and company signals

Funding stage: M And A
Funding rounds: 1
Total equity funding: $32M
Last funding: Series B / $32M / 2004-03-08
Last equity funding: Series B / $32M
Investors: 6
Lead investors: 1
Exited on: 2006-05-24

Categories and groups

Biotechnology Health Care Life Science Biotechnology Health Care Science and Engineering

Founders and investors

Lead investors

Index Ventures

Investors

BioMedPartnersGimvGlobal Life Science VenturesIndex VenturesSofinnova Investments

People at this company

Preview only. Contact details are available after you sign in.

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Shipment records and coverage can change as the dataset is updated.